کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3330153 1590724 2006 15 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی هماتولوژی
پیش نمایش صفحه اول مقاله
Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: A systematic literature review
چکیده انگلیسی

Increasing numbers of men with non-metastatic disease are receiving androgen deprivation therapy (ADT) for a variety of indications, some of which are supported by evidence from randomized trials. Balanced against possible survival benefits and better disease control are data that ADT adversely affects quality of life, particularly in the areas of sexual function, physical function, and energy. There is some evidence of worsening upper extremity physical strength but no clear evidence of decline in daily function with ADT. The impact of ADT on cognitive function is not clear at this time. ADT is associated with declines in bone mineral density within 6–12 months of commencing treatment, with increased fracture rates within 5 years of treatment. ADT use is also associated with a 10–15 g/L decline in hemoglobin, although the clinical significance of this drop appears to be limited for most patients. It is reasonable for physicians who are about to start men on ADT to obtain a baseline bone mineral density, to counsel them about the impact on sexual function and possible treatments for sexual dysfunction, and to encourage regular exercise. Further insight into adverse effects of ADT and strategies to minimize these adverse effects await data from ongoing studies.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Critical Reviews in Oncology/Hematology - Volume 60, Issue 3, December 2006, Pages 201–215
نویسندگان
, , ,